The Effects of Postoperative Neurological Deficits on Survival in Patients With Single Brain Metastasis.
暂无分享,去创建一个
[1] G. Tortora,et al. Oncogene-Addicted Non-Small-Cell Lung Cancer: Treatment Opportunities and Future Perspectives , 2020, Cancers.
[2] R. Amaria,et al. Incidence, patterns of progression, and outcomes of preexisting and newly discovered brain metastases during treatment with anti–PD‐1 in patients with metastatic melanoma , 2019, Cancer.
[3] Timothy K. Nguyen,et al. Predictors of Leptomeningeal Disease Following Hypofractionated Stereotactic Radiotherapy for Intact and Resected Brain Metastases. , 2019, Neuro-oncology.
[4] B. Han,et al. Management of Central Nervous System Metastases in Patients With Advanced Anaplastic Lymphoma Kinase-Rearranged Non-Small-Cell Lung Cancer During Crizotinib Treatment. , 2019, Clinical lung cancer.
[5] Hongwei Guo,et al. Anaplastic lymphoma kinase inhibitors in non-small cell lung cancer patients with brain metastases: a meta-analysis. , 2019, Journal of thoracic disease.
[6] J. Olson,et al. Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines on the Use of Stereotactic Radiosurgery in the Treatment of Adults With Metastatic Brain Tumors , 2019, Neurosurgery.
[7] M. Suarez‐Almazor,et al. Managing toxicities associated with immune checkpoint inhibitors: consensus recommendations from the Society for Immunotherapy of Cancer (SITC) Toxicity Management Working Group , 2017, Journal of Immunotherapy for Cancer.
[8] Eudocia Q Lee,et al. Incidence and prognosis of patients with brain metastases at diagnosis of systemic malignancy: a population-based study , 2017, Neuro-oncology.
[9] J. Buckner,et al. Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC·3): a multicentre, randomised, controlled, phase 3 trial. , 2017, The Lancet. Oncology.
[10] F. Bova,et al. The effects of new or worsened postoperative neurological deficits on survival of patients with glioblastoma. , 2017, Journal of neurosurgery.
[11] G. Long,et al. Survival of patients with melanoma brain metastasis treated with stereotactic radiosurgery and active systemic drug therapies. , 2017, European journal of cancer.
[12] Volker W Stieber,et al. Effect of Radiosurgery Alone vs Radiosurgery With Whole Brain Radiation Therapy on Cognitive Function in Patients With 1 to 3 Brain Metastases: A Randomized Clinical Trial. , 2016, JAMA.
[13] E. Kekilli,et al. Survival and prognostic factors in patients with brain metastasis: Single center experience. , 2016, Journal of B.U.ON. : official journal of the Balkan Union of Oncology.
[14] P. Nakaji,et al. The Current and Future Treatment of Brain Metastases , 2016, Front. Surg..
[15] Yan Yuan,et al. Canadian brain cancer survival rates by tumour type and region: 1992–2008 , 2016, Canadian Journal of Public Health.
[16] Walter F. Wiggins,et al. A new treatment paradigm: neoadjuvant radiosurgery before surgical resection of brain metastases with analysis of local tumor recurrence. , 2014, International journal of radiation oncology, biology, physics.
[17] B. Meyer,et al. Postoperative ischemic changes following brain metastasis resection as measured by diffusion-weighted magnetic resonance imaging. , 2013, Journal of neurosurgery.
[18] K. Stelzer,et al. Epidemiology and prognosis of brain metastases , 2013, Surgical neurology international.
[19] Steven D Chang,et al. Risk of leptomeningeal disease in patients treated with stereotactic radiosurgery targeting the postoperative resection cavity for brain metastases. , 2012, International journal of radiation oncology, biology, physics.
[20] J. Joo,et al. Incidence and Risk Factors for Leptomeningeal Carcinomatosis in Breast Cancer Patients with Parenchymal Brain Metastases , 2012, Journal of Korean Neurosurgical Society.
[21] M. Smyth,et al. Characterization of the supplementary motor area syndrome and seizure outcome after medial frontal lobe resections in pediatric epilepsy surgery. , 2012, Neurosurgery.
[22] A. Olivi,et al. Factors involved in maintaining prolonged functional independence following supratentorial glioblastoma resection. Clinical article. , 2011, Journal of neurosurgery.
[23] Alfredo Quinones-Hinojosa,et al. ASSOCIATION OF SURGICALLY ACQUIRED MOTOR AND LANGUAGE DEFICITS ON OVERALL SURVIVAL AFTER RESECTION OF GLIOBLASTOMA MULTIFORME , 2009, Neurosurgery.
[24] Akash J. Patel,et al. COMPARATIVE RISK OF LEPTOMENINGEAL DISSEMINATION OF CANCER AFTER SURGERY OR STEREOTACTIC RADIOSURGERY FOR A SINGLE SUPRATENTORIAL SOLID TUMOR METASTASIS , 2009, Neurosurgery.
[25] Akash J. Patel,et al. Comparative risk of leptomeningeal disease after resection or stereotactic radiosurgery for solid tumor metastasis to the posterior fossa. , 2008, Journal of neurosurgery.
[26] A. Young,et al. Recursive Partitioning Analysis Classifications I and II: Applicability Evaluated in a Randomized Trial for Resected Single Brain Metastases , 2004, American journal of clinical oncology.
[27] Jill S Barnholtz-Sloan,et al. Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[28] J. Gilsbach,et al. Prognostic Factors for Patients with Microsurgically Resected Brain Metastases , 2002, Oncology Research and Treatment.
[29] A. Twijnstra,et al. Incidence of brain metastases in a cohort of patients with carcinoma of the breast, colon, kidney, and lung and melanoma , 2002, Cancer.
[30] G. Schackert,et al. Surgical Management of Single and Multiple Brain Metastases: Results of a Retrospective Study , 2001, Oncology Research and Treatment.
[31] W. Hall,et al. Long-term survival with metastatic cancer to the brain , 2000, Medical oncology.
[32] P. Levendag,et al. Identification of prognostic factors in patients with brain metastases: a review of 1292 patients. , 1999, International journal of radiation oncology, biology, physics.
[33] M. J. van den Bent,et al. Leptomeningeal metastasis after surgical resection of brain metastases , 1999, Journal of neurology, neurosurgery, and psychiatry.
[34] L Gaspar,et al. Recursive partitioning analysis (RPA) of prognostic factors in three Radiation Therapy Oncology Group (RTOG) brain metastases trials. , 1997, International journal of radiation oncology, biology, physics.
[35] L. K. Norris,et al. Neoplastic meningitis following surgical resection of isolated cerebellar metastasis: A potentially preventable complication , 1997, Journal of Neuro-Oncology.
[36] G. Duncan,et al. A randomized trial to assess the efficacy of surgery in addition to radiotherapy in patients with a single cerebral metastasis , 1996, Cancer.
[37] Ronald Brand,et al. Treatment of single brain metastasis: Radiotherapy alone or combined with neurosurgery , 1993, Annals of neurology.
[38] Y Maruyama,et al. A randomized trial of surgery in the treatment of single metastases to the brain. , 1990, The New England journal of medicine.
[39] G. Krol,et al. Distribution of brain metastases. , 1988, Archives of neurology.
[40] Y. Kluger,et al. Long-Term Survival of Patients With Melanoma With Active Brain Metastases Treated With Pembrolizumab on a Phase II Trial. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[41] K. Thomas,et al. Leptomeningeal Disease and the Evolving Role of Molecular Targeted Therapy and Immunotherapy. , 2017, The Ochsner journal.
[42] U. Nestle,et al. Prognostic factors in brain metastases: should patients be selected for aggressive treatment according to recursive partitioning analysis (RPA) classes? , 2000, International journal of radiation oncology, biology, physics.
[43] W Curran,et al. Validation of the RTOG recursive partitioning analysis (RPA) classification for brain metastases. , 2000, International journal of radiation oncology, biology, physics.